Reducing Opioid Use for Chronic Pain Patients Following Surgery

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Sep 17, 2018

Keywords

ClinConnect Summary

This clinical trial, called the Transitional Pain Service Program (TPSP), is designed to help patients with chronic pain reduce their use of opioids after surgery. Opioids are strong pain medications that can lead to serious problems if used for a long time. The TPSP at Toronto General Hospital offers support through pain education, therapy, and a mobile app to help patients manage their pain without relying heavily on opioids. The goal is to help patients find a balance between managing their pain effectively and minimizing the risks associated with opioid use.

To participate in this trial, you need to be at least 18 years old and currently taking between 20 to 200 mg of oral morphine each day for at least one month before your surgery. You should also be able to read and understand English, and have a personal email for using the app provided in the program. Participants will work with a team to learn new ways to handle pain and reduce their opioid intake, ultimately aiming for better long-term health and well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ≥ 18 years of age
• • Taking 20 -- 200 mg of preoperative oral morphine equivalents daily
• • Any type of surgical procedure, with the exception of those with palliative intent or organ transplantation
• • Able to read and understand English as posed on the questionnaire surveys prior to informed consent
• • Must be taking opioids for at least one month prior to their operation
• • Must have a personal email address for the set-up of the Manage My Pain (MMP) App or online multimedia tool
• Exclusion Criteria:
• • • Subjects who are undergoing palliative care or procedures, organ transplantation, or prescribed with Methadone/Buprenorphine will be excluded from the trial